Enbrel, Etanercept Wire
Comprehensive News Feed for Enbrel, Etanercept (generic).
Results 1 - 20 of 243 in Enbrel, Etanercept (generic)
-
Why J&J's Stelara Launch Should Target Dermatologists First
Although Stelara is entering a crowded treatment room for psoriasis, this first-in-class interleukin inhibitor could put the "no more tears" back in J&J's future - if successfully marketed to specialists, in particular dermatologists, as it is a novel and less cumbersome injectable than established biologics for psoriasis, the tumor necrosis ... Comment?
-
What Arthritis Patients Should Know About Biologics
w/Photo
In the late 1990s, the first of several biologics went on the market to treat rheumatoid arthritis . Comment?
-
Receive a FREE Osteoarthritis of the knee pamphlet. Start here. Anyone just taking a low dosage of Prednisone to treat Rheumatoid Arthritis? 11/18/09 I am just taking 5 mg Prednisone for Rheumatoid Arthritis & I feel pretty good except sometimes very tired. Comment?
-
Darkening of the gums...RX side effects?
Establish a relationship with your doctor that works for you. I have recently experienced dark places on my lower gums. Comment?
-
advice on medicines in rhemutoid arthiritis
Receive a FREE Osteoarthritis of the knee pamphlet. Start here. advice on medicines in rhemutoid arthiritis 11/18/09 mariam Topics: Medicines on Rhemutoid hi! I have tried humira, embrel and orencia along with methotrexate but still my sed rate does not go down and i am in lot of pain and stifness. Comment?
-
Golimumab shows promise for rheumatoid arthritis
Golimumab, a new tumour necrosis factor-I inhibitor reduces the signs and symptoms of rheumatoid arthritis in patients who have previously received any other TNF-I inhibitor, and might be a good option for patients who have inadequate responses to one or two other TNF-I inhibitors, finds an Article published Online first and in this week's edition ... Comment?
-
Survey shows majority of rheumatologists would prescribe Actemra drug for rheumatoid arthritis
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that 98 percent of surveyed rheumatologists indicate they will prescribe Roche's Actemra, an interleukin-6 inhibitor, for the treatment of rheumatoid arthritis following the agent's expected launch in 2010. Comment?
-
Decision Resources: Biosimilars may cause biotech companies to lose more than $9 billion
WALTHAM,A Mass. Biotech companies that manufacture a class of drugs used to treat autoimmune disorders stand to lose more than $9 billion in Europe and the United States by 2018 thanks to competition from biosimilars, according to a report. Comment?
-
Arthritis Drugs Unlikely to Increase Cancer Risk
w/Photo
Rheumatoid arthritis patients who start taking anti-tumor necrosis factor I drugs are not likely to have a higher risk of developing cancer than other groups of RA patients, according to a Swedish study in the November issue of Arthritis & Rheumatism . Comment?
-
Arthritis Drugs Unlikely to Increase Cancer Risk
w/Photo
Rheumatoid arthritis patients who start taking anti-tumor necrosis factor I drugs are not likely to have a higher risk of developing cancer than other groups of RA patients, according to a Swedish study in the November issue of Arthritis & Rheumatism . Comment?
-
TNF-alpha inhibitors ranked top for reducing biologics spend
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that biosimilars of tumor necrosis factor -alpha inhibitors stand to erode $9.6 billion in brand sales in the U.S. and Europe by 2018. Comment?
-
Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel,...
Tumor Necrosis Factor Blockers August 2009 August 31, 2009 Audience: Rheumatologists, gastroenterologists, oncologists, dermatologists [UPDATED 08/31/2009] Supplemental Q&As added [Posted 08/04/2009] FDA notified healthcare professionals that it has completed its analysis of tumor necrosis factor blockers and has concluded that there is an ... Comment?
-
TNF Blockers Do Not Increase Cancer Risk in Rheumatoid Arthritis Patients
A Swedish study has concluded that rheumatoid arthritis patients did not experience an increased cancer risk in the first 6 years of treatment with TNF blockers . Comment?
-
Study Eases Arthritis Drug Cancer Fears
Oct. 29, 2009 -- Rheumatoid arthritis patients who take the biologic drugs Remicade , Humira , and Enbrel do not appear to have an increased risk for developing cancer in the first few years of use, researchers in Sweden report. Comment?
-
Rheumatoid Arthritis Treatment Doesn't Promote Cancer
w/Photo
Treatment with tumor necrosis factor blockers doesn't increase rheumatoid arthritis patients' risk of cancer, new research has found. Comment?
-
Anti-Tumor Necrosis Factor Treatment Does Not Increase Cancer Risk In RAPpatients
A recent study by Swedish researchers found that rheumatoid arthritis patients did not experience an elevated cancer risk in the first 6 years after starting anti-tumor necrosis factor therapy. Comment?
-
Watching insiders is like participating in a weeks-long stakeout. You expect something to happen, but you don't know what. Comment?
-
Watching insiders is like participating in a weeks-long stakeout. You expect something to happen, but you don't know what. Comment?
-
Anti-tumor necrosis factor treatment does not increase cancer Risk in RA patients
w/Photo
A recent study by Swedish researchers found that rheumatoid arthritis patients did not experience an elevated cancer risk in the first 6 years after starting anti-tumor necrosis factor therapy. Comment?
-
Weighing Pain Relief and Cancer Risk
During the past decade, a new class of drugs, called TNF inhibitors, has improved the lives of tens of thousands of people who suffer from painful autoimmune diseases including rheumatoid arthritis, psoriatic arthritis, and Crohn's disease. Comment?
Enbrel, Etanercept Forum
Most Popular
- Jesse Jackson Says Black Men 'Can't Vote Against Healthcare', Media Mostly Mum - 232 comments
- Historic health care bill clears Senate hurdle - 175 comments
- Texas kid beaten with metal pole, entirely preventable - 147 comments
- Dr. Paolo Zamboni at his research lab at the University of Ferrara - 64 comments
- Obama inspires; Palin connects - 106 comments
- Woman Loses Disability Insurance Over Facebook Photos - 110 comments
- Being gay is not a choice. What if it were? - 152 comments
- Defense Attorney: Hasan Is Paralyzed From the Chest Down - 96 comments
- Woman Arrested After Cutting Line Claims Racism - 45 comments
- Sarah Palin "Just Plain Nutz" On Sale - 66 comments
|
Reach local customers. Engage a specific demographic. Maximize business-to-business opportunities. Topix can deliver your message.
|
Copyright ©2009 Topix LLC
